MYM Shareholders Approve Plan of Arrangement with IM Cannabis
VANCOUVER, British Columbia, July 05, 2021 (GLOBE NEWSWIRE) — MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or the “Company”),…
Pharmaceuticals, Biotechnology and Life Sciences
VANCOUVER, British Columbia, July 05, 2021 (GLOBE NEWSWIRE) — MYM Nutraceuticals Inc., (CSE: MYM) (OTCBB: MYMMF) (“MYM” or the “Company”),…
OSLO, Norway, July 05, 2021 (GLOBE NEWSWIRE) — Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory…
Oslo, 5 July 2021: Ultimovacs ASA (“Ultimovacs”) (OSE ULTI), a clinical stage leader in immune stimulatory vaccines for cancer, today…
2021 OutlookThe animal health sector has shown excellent dynamism in the first months of 2021. A number of indicators, such…
Saint Herblain (France), July 5, 2021 –Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company focused on the…
THIS ANNOUNCEMENT CONTAINS REGULATED INFORMATION. PUBLICATION RELATING TO A TRANSPARENCY NOTIFICATION(ARTICLE 14, 1ST PARAGRAPH, OF THE LAW OF 2 MAY…
— ORR of 72% Observed in Patients with >2L HER2 Positive Gastric or Gastroesophageal Junction Cancer — Estimated OS at 12…
CAMBRIDGE, Mass., July 01, 2021 (GLOBE NEWSWIRE) — Cerevel Therapeutics (Nasdaq: CERE), a company dedicated to unraveling the mysteries of…
SHANGHAI, China, July 02, 2021 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated…
HANGZHOU, China, July 02, 2021 (GLOBE NEWSWIRE) — Hangzhou Chance Pharmaceuticals (“Chance”), a clinical-stage biotechnology company focusing on discovering, developing,…